HURA
TuHURA Biosciences Inc.

15,701
Loading...
Loading...
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors. The company was founded on May 4, 2023 and is headquartered in Tampa, FL.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
19

Frequently Asked Questions

What is Market Cap of TuHURA Biosciences Inc.?
What is the 52-week high for TuHURA Biosciences Inc.?
What is the 52-week low for TuHURA Biosciences Inc.?
What is TuHURA Biosciences Inc. stock price today?
What was TuHURA Biosciences Inc. stock price yesterday?
What is the PE ratio of TuHURA Biosciences Inc.?
What is the Price-to-Book ratio of TuHURA Biosciences Inc.?
What is the 50-day moving average of TuHURA Biosciences Inc.?
How many employess does TuHURA Biosciences Inc. has?

Latest HURA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.